A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.
The FDA and CDC recommend getting the new COVID vaccine to fight the new variants spreading this fall. Florida Surgeon ...
It’s no wonder that national health experts have taken a dim view on Ladapo’s latest health-advisory stunt on COVID vaccines.
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Corp. with ...
The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against serious COVID-19 impacts.
The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...
On the other hand, by late fall the major variants may have changed, rendering the vaccine less effective, said Peter Marks, the FDA’s top vaccine official, at a briefing Aug. 23. He urged everyone ...
9h
Valneva SE (VALN) said that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to potentially expand the use of its chikungunya vaccine, IXCHIQ, to ...
The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...
On Aug. 31, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating ...
Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according to Agriculture Secretary Francisco Tiu Laurel Jr.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback